Manuel Gómez Selected Research

Manuel Gómez Research Topics

Disease

4	Respiratory Tract Infections (Respiratory Tract Infection) 01/2018 - 01/2010
3	Infections 11/2014 - 05/2003
3	Pharyngitis (Sore Throat) 11/2014 - 01/2010
3	Inflammation (Inflammations) 08/2010 - 09/2003
2	Death (Near-Death Experience) 01/2022 - 01/2020
2	Brain Death (Brain Dead) 01/2020 - 04/2003
2	Pneumonia (Pneumonitis) 01/2020 - 01/2010
2	Neoplasms (Cancer) 01/2015 - 02/2004
2	Tonsillitis 11/2014 - 01/2010
2	Common Cold 11/2014 - 03/2013
2	Experimental Arthritis 01/2009 - 09/2003
2	Arthritis (Polyarthritis) 12/2006 - 10/2006
1	Opioid-Related Disorders (Opiate Addiction) 01/2022
1	Migraine Disorders (Migraine) 01/2022
1	Constipation 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Pain (Aches) 12/2021
1	Idiopathic Pulmonary Fibrosis 08/2021
1	COVID-19 08/2021
1	Weight Loss (Weight Reduction) 10/2020
1	Rupture 04/2016
1	Stroke (Strokes) 06/2015
1	Atrial Fibrillation 06/2015
1	Bronchitis 11/2014
1	Rhinosinusitis 12/2012
1	Myocardial Infarction 01/2012
1	Contact Dermatitis (Eczema, Contact) 08/2010
1	Asthma (Bronchial Asthma) 08/2010
1	Hypersensitivity (Allergy) 08/2010
1	Otitis Media 01/2010
1	Cough 01/2010
1	Fever (Fevers) 01/2010
1	Atherosclerotic Plaque (Atheroma) 01/2009
1	Atherosclerosis 01/2009
1	Cholangiocarcinoma 02/2004
1	End Stage Liver Disease 05/2003
1	Ischemia 05/2003
1	Brain Hypoxia (Cerebral Hypoxia) 04/2003
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 04/2003
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 04/2003
1	Craniocerebral Trauma (Head Injury) 04/2003
1	B-Cell Lymphoma (Lymphoma, B Cell) 04/2003
1	Lymphoma (Lymphomas) 04/2003

Drug/Important Bio-Agent (IBA)

7	Anti-Bacterial Agents (Antibiotics)IBA 01/2018 - 01/2010
3	Monoclonal AntibodiesIBA 01/2022 - 04/2003
2	CholesterolIBA 01/2022 - 01/2009
2	Collagen Type II (Type II Collagen)IBA 12/2006 - 10/2006
1	Buprenorphine (Subutex)FDA LinkGeneric 01/2022
1	Naloxone Drug Combination Buprenorphine FDA Link 01/2022
1	Methadone (Dolophine)FDA LinkGeneric 01/2022
1	Calcitonin Gene-Related PeptideIBA 01/2022
1	nintedanibIBA 08/2021
1	pirfenidoneIBA 08/2021
1	Antifibrotic AgentsIBA 08/2021
1	xanthan gum (xanthan)FDA LinkGeneric 10/2020
1	Psyllium (Metamucil)IBA 10/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	dicarboxydine (DCD)IBA 01/2020
1	MetalsIBA 04/2016
1	pyridineIBA 04/2016
1	ChlorineIBA 04/2016
1	AnticoagulantsIBA 06/2015
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2015
1	C-Reactive ProteinIBA 12/2012
1	AntigensIBA 08/2010
1	OvalbuminIBA 08/2010
1	OxazoloneIBA 08/2010
1	AllergensIBA 08/2010
1	AntibodiesIBA 08/2010
1	HaptensIBA 08/2010
1	Interferon-gamma (Interferon, gamma)IBA 01/2009
1	Cell Surface ReceptorsIBA 01/2009
1	ApolipoproteinsIBA 01/2009
1	Apolipoproteins E (ApoE)IBA 01/2009
1	LipidsIBA 01/2009
1	Interleukin-10 (Interleukin 10)IBA 01/2009
1	CytokinesIBA 09/2003
1	Transforming Growth Factor beta (TGF-beta)IBA 09/2003
1	Serum AlbuminIBA 05/2003
1	Rituximab (Mabthera)FDA Link 04/2003
1	Cocaine (Cocaine HCl)IBA 04/2003
1	CD20 AntigensIBA 04/2003

Therapy/Procedure

6	Liver Transplantation 01/2022 - 04/2003
3	Therapeutics 01/2022 - 01/2010
1	Dry Needling 12/2021
1	Patient Readmission 01/2012
1	Transplantation 02/2004
1	Palliative Care (Palliative Therapy) 02/2004
1	Artificial Respiration (Mechanical Ventilation) 05/2003